IL327495A - Process for manufacturing loxavir marboxil - Google Patents

Process for manufacturing loxavir marboxil

Info

Publication number
IL327495A
IL327495A IL327495A IL32749526A IL327495A IL 327495 A IL327495 A IL 327495A IL 327495 A IL327495 A IL 327495A IL 32749526 A IL32749526 A IL 32749526A IL 327495 A IL327495 A IL 327495A
Authority
IL
Israel
Prior art keywords
baloxavir
process according
csa
compound
reactor
Prior art date
Application number
IL327495A
Other languages
English (en)
Hebrew (he)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL327495A publication Critical patent/IL327495A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Animal Behavior & Ethology (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
IL327495A 2023-10-05 2024-10-03 Process for manufacturing loxavir marboxil IL327495A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP23201730 2023-10-05
PCT/EP2024/077821 WO2025073819A2 (en) 2023-10-05 2024-10-03 Process for manufacturing baloxavir marboxil

Publications (1)

Publication Number Publication Date
IL327495A true IL327495A (en) 2026-05-01

Family

ID=88291225

Family Applications (1)

Application Number Title Priority Date Filing Date
IL327495A IL327495A (en) 2023-10-05 2024-10-03 Process for manufacturing loxavir marboxil

Country Status (8)

Country Link
EP (1) EP4788681A2 (es)
KR (1) KR20260085417A (es)
CN (1) CN121925422A (es)
AR (1) AR134053A1 (es)
AU (1) AU2024355785A1 (es)
IL (1) IL327495A (es)
TW (1) TW202530224A (es)
WO (1) WO2025073819A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN121127476A (zh) * 2024-03-18 2025-12-12 石药集团中奇制药技术(石家庄)有限公司 多环吡啶酮衍生物及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107709321A (zh) 2015-04-28 2018-02-16 盐野义制药株式会社 经取代的多环性吡啶酮衍生物及其前药
US11261198B2 (en) 2016-06-20 2022-03-01 Shionogi & Co., Ltd. Process for preparing substituted polycyclic pyridone derivative and crystal thereof

Also Published As

Publication number Publication date
AR134053A1 (es) 2025-11-26
WO2025073819A3 (en) 2025-05-15
CN121925422A (zh) 2026-04-24
TW202530224A (zh) 2025-08-01
WO2025073819A2 (en) 2025-04-10
EP4788681A2 (en) 2026-08-12
AU2024355785A1 (en) 2026-03-26
KR20260085417A (ko) 2026-06-09

Similar Documents

Publication Publication Date Title
GB2620828B (en) Process
GB202301309D0 (en) Process
GB202317474D0 (en) Process
GB202301443D0 (en) Process
GB202210917D0 (en) Process
IL318516A (en) process
GB202205978D0 (en) Process
IL319979A (en) ALOGABAT production process
EP3922621C0 (de) Prozess zur herstellung von propylen
GB202300914D0 (en) Manufacturing process
GB2619949B (en) Process
CA3306948A1 (en) Process for manufacturing baloxavir marboxil
CA3271589A1 (en) Process for manufacturing alogabat
GB202405519D0 (en) Process
GB202405510D0 (en) Process
GB202403857D0 (en) Process
GB202401015D0 (en) Process
GB202317929D0 (en) Process
GB202317389D0 (en) Process
GB202315169D0 (en) Process
GB202312435D0 (en) Process
GB202310276D0 (en) Process
GB202306877D0 (en) Process
GB202306158D0 (en) Process
GB202306076D0 (en) Process